DAVITA INC. Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax
DAVITA INC. (DVA) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax of -$2.50 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-01.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax · last filed 2013-03-01
- DAVITA INC. other comprehensive income (loss), derivatives qualifying as hedges, tax for fiscal 2012 was -$2.50M, a 120.30% decline from fiscal 2011.
- DAVITA INC. other comprehensive income (loss), derivatives qualifying as hedges, tax for fiscal 2011 was $12.30M.
- DAVITA INC. other comprehensive income (loss), derivatives qualifying as hedges, tax for fiscal 2010 was -$3.45M.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax 12 month |
|---|---|
| 2012-12-31 | -$2.50M 10-K · filed 2013-03-01 |
| 2011-12-31 | $12.30M 10-K · filed 2013-03-01 |
| 2010-12-31 | -$3.45M 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |